Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Insulin: an endogenous cardioprotector.

Undurti N Das1

  • 1EFA Sciences LLC, Norwood, Massachusetts 02062, USA. Undurti@hotmail.com

Current Opinion in Critical Care
|September 26, 2003
PubMed
Summary

The insulin/glucose-insulin-potassium (GIK) regimen offers myocardial protection by reducing inflammation and free radicals, preserving heart function during critical illness. This cardioprotective effect aids recovery in conditions like acute myocardial infarction and sepsis.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Lipoxin A 4 (LXA 4 ) for diabetic retinopathy (DR).

Indian journal of ophthalmology·2026
Same author

Effect of essential fatty acids (EFAs) and their metabolites on the growth suppressive action of anti-cancer drug doxorubicin on neuro- and glioblastoma cells in vitro.

Prostaglandins & other lipid mediators·2026
Same author

Arachidonic Acid and Lipoxin A4 Protect Pancreatic β-Cells and Improve Hyperglycemia Induced by Bleomycin.

Journal of biochemical and molecular toxicology·2026
Same author

Is Sepsis an Essential Fatty Acids Deficiency State?

Indian journal of critical care medicine : peer-reviewed, official publication of Indian Society of Critical Care Medicine·2025
Same author

Why vitamin C and corticosteroids are inadequate and how essential fatty acids (EFAs) can augment recovery from sepsis.

Nutrition (Burbank, Los Angeles County, Calif.)·2025
Same author

Arachidonic Acid Protects Skeletal Muscle Against Hyperglycaemia-Induced Muscle Atrophy by Modulating Myogenesis and Regulating KLF15 Expression in C57Bl/6 Mice.

FASEB journal : official publication of the Federation of American Societies for Experimental Biology·2025

Area of Science:

  • Cardiology
  • Endocrinology
  • Critical Care Medicine

Background:

  • Insulin is primarily known for glucose homeostasis.
  • Emerging evidence suggests insulin possesses unique cardioprotective properties.
  • The glucose-insulin-potassium (GIK) regimen is explored for its therapeutic potential beyond glycemic control.

Purpose of the Study:

  • To review the myocardial protective properties of the insulin/GIK regimen.
  • To elucidate the underlying mechanisms of insulin's cardioprotective action.
  • To discuss the clinical implications in various critical conditions.

Main Methods:

  • Review of recent scientific literature on insulin and GIK regimen.
  • Analysis of studies investigating insulin's effects on myocardial cells and inflammatory pathways.

Related Experiment Videos

  • Examination of clinical data related to GIK regimen use in cardiovascular and critical illnesses.

    • Main Results:

    • Insulin/GIK regimen protects the myocardium from ischemia-reperfusion injury and apoptosis.
    • The regimen suppresses pro-inflammatory cytokines (e.g., TNF-alpha, IL-6) and free radicals.
    • It enhances endothelial nitric oxide and anti-inflammatory cytokines (e.g., IL-4, IL-10) synthesis.
    • Insulin/GIK demonstrates efficacy in sepsis, septic shock, acute myocardial infarction, and critical illness.

    Conclusions:

    • The insulin/GIK regimen exerts cardioprotection through anti-inflammatory and antioxidant mechanisms.
    • This regimen is beneficial for preserving myocardial integrity and function in acute myocardial infarction, heart failure, and critical illness.
    • Timely administration of insulin/GIK may offer protective benefits to other organs in critically ill patients.